Vycor Medical, Inc. (VYCO)
OTCMKTS · Delayed Price · Currency is USD
0.0660
+0.0090 (15.79%)
Jun 17, 2026, 4:00 PM EST
Vycor Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.17 | 0.09 | 0.11 | 0.06 | 0.04 | 0.09 |
Cash & Short-Term Investments | 0.17 | 0.09 | 0.11 | 0.06 | 0.04 | 0.09 |
Cash Growth | 184.42% | -17.67% | 84.41% | 54.69% | -59.28% | 97.69% |
Receivables | 0.19 | 0.22 | 0.25 | 0.22 | 0.16 | 0.13 |
Inventory | 0.18 | 0.16 | 0.15 | 0.23 | 0.25 | 0.21 |
Prepaid Expenses | 0.1 | 0.1 | 0.12 | 0.08 | 0.07 | 0.06 |
Other Current Assets | - | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 0.65 | 0.56 | 0.62 | 0.58 | 0.52 | 0.49 |
Property, Plant & Equipment | 0.16 | 0.19 | 0.3 | 0.4 | 0.34 | 0.44 |
Other Long-Term Assets | 0.04 | 0.08 | 0.08 | 0.01 | 0.01 | 0.01 |
Total Assets | 0.85 | 0.83 | 1 | 0.99 | 0.86 | 0.94 |
Accounts Payable | 0.09 | 0.08 | 0.15 | 0.12 | 0.2 | 0.23 |
Accrued Expenses | 0.93 | 0.88 | 0.87 | 0.8 | 2.59 | 2.2 |
Short-Term Debt | 0.81 | 0.82 | 0.82 | 0.82 | 0.82 | 0.64 |
Current Portion of Leases | 0.04 | 0.05 | 0.05 | 0.05 | 0.03 | 0.05 |
Other Current Liabilities | 3.08 | 2.94 | 2.62 | 2.29 | 0.02 | 0.03 |
Total Current Liabilities | 4.95 | 4.78 | 4.5 | 4.07 | 3.65 | 3.15 |
Long-Term Debt | 0.13 | 0.14 | 0.14 | 0.14 | 0.15 | 0.15 |
Long-Term Leases | - | - | 0.05 | 0.1 | - | 0.03 |
Total Liabilities | 5.08 | 4.92 | 4.69 | 4.32 | 3.8 | 3.33 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 29.43 | 29.43 | 29.43 | 29.37 | 29.36 | 29.17 |
Retained Earnings | -33.79 | -33.65 | -33.25 | -32.82 | -32.43 | -31.7 |
Treasury Stock | -0 | -0 | -0 | -0 | -0 | -0 |
Comprehensive Income & Other | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
Total Common Equity | -4.23 | -4.09 | -3.69 | -3.33 | -2.94 | -2.4 |
Shareholders' Equity | -4.23 | -4.09 | -3.69 | -3.33 | -2.94 | -2.4 |
Total Liabilities & Equity | 0.85 | 0.83 | 1 | 0.99 | 0.86 | 0.94 |
Total Debt | 0.98 | 1.01 | 1.06 | 1.11 | 0.99 | 0.87 |
Net Cash (Debt) | -0.81 | -0.92 | -0.95 | -1.05 | -0.96 | -0.78 |
Net Cash Per Share | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
Filing Date Shares Outstanding | 33.37 | 33.37 | 33.37 | 32.63 | 32.63 | 31.46 |
Total Common Shares Outstanding | 33.37 | 33.37 | 33.37 | 32.63 | 32.53 | 30.82 |
Working Capital | -4.3 | -4.22 | -3.88 | -3.49 | -3.14 | -2.66 |
Book Value Per Share | -0.13 | -0.12 | -0.11 | -0.10 | -0.09 | -0.08 |
Tangible Book Value | -4.23 | -4.09 | -3.69 | -3.33 | -2.94 | -2.4 |
Tangible Book Value Per Share | -0.13 | -0.12 | -0.11 | -0.10 | -0.09 | -0.08 |
Machinery | - | 1.01 | 1 | 1 | 0.99 | 0.99 |
Leasehold Improvements | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |